ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced that seven abstracts have been accepted as poster presentations at the Muscular Dystrophy Association (MDA) Clinical and ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new ...

On Saturday 15 February 2025, the first official presentation of the new and 40th book by the French-Cameroonian ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for people living with genetically driven diseases, today ...

today announced that the company will be presenting two oral and five poster presentations at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference being held March 16-19 ...

will be featured in presentations at the 2025 American Association for the Advancement of Science Annual Meeting, which is being held at the Hynes Convention Center in Boston, MA from February 13 ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

Details of the presentations are as follows: 2025 American Association for the Advancement of Science Annual Meeting Session: Science Breakthroughs Title: Unleashing Immune Cells on Autoimmune ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

A health district epidemiologist called it a “kick in the teeth” and “based on conspiracy and misinformation.” ...

Session: Session 9: Targeting Non-malignant DiseasesTitle: Clinical and Translational Studies of Rese-cel (an anti-CD19 CAR T Therapy) in Myositis, SLE, and Systemic Sclerosis: RESET Phase I/II ...

It was an ambitious theme for a premier science conference: Organizers of the American Association for the Advancement of ...